Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Net Cash Flow (2019 - 2025)

Historic Net Cash Flow for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to $11.7 million.

  • Eton Pharmaceuticals' Net Cash Flow rose 35742.11% to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.9 million, marking a year-over-year increase of 103200.66%. This contributed to the annual value of -$6.5 million for FY2024, which is 22693.29% down from last year.
  • Eton Pharmaceuticals' Net Cash Flow amounted to $11.7 million in Q3 2025, which was up 35742.11% from $8.0 million recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' Net Cash Flow registered a high of $11.7 million during Q3 2025, and its lowest value of -$8.3 million during Q4 2021.
  • For the 5-year period, Eton Pharmaceuticals' Net Cash Flow averaged around $796263.2, with its median value being $823000.0 (2022).
  • Its Net Cash Flow has fluctuated over the past 5 years, first skyrocketed by 2281250.0% in 2022, then crashed by 68079.18% in 2024.
  • Eton Pharmaceuticals' Net Cash Flow (Quarter) stood at -$8.3 million in 2021, then soared by 135.25% to $2.9 million in 2022, then plummeted by 123.3% to -$682000.0 in 2023, then tumbled by 680.79% to -$5.3 million in 2024, then soared by 320.51% to $11.7 million in 2025.
  • Its Net Cash Flow stands at $11.7 million for Q3 2025, versus $8.0 million for Q2 2025 and $2.5 million for Q1 2025.